Paige Gosling Wickner, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Hypersensitivity | 19 | 2023 | 903 | 2.910 |
Why?
|
Anaphylaxis | 9 | 2021 | 755 | 1.420 |
Why?
|
Hypersensitivity | 8 | 2023 | 1168 | 1.250 |
Why?
|
beta-Lactams | 5 | 2023 | 158 | 0.970 |
Why?
|
Desensitization, Immunologic | 4 | 2021 | 546 | 0.700 |
Why?
|
Progestins | 2 | 2020 | 302 | 0.600 |
Why?
|
Checklist | 2 | 2020 | 842 | 0.520 |
Why?
|
Skin Tests | 7 | 2023 | 630 | 0.460 |
Why?
|
Medical Records | 1 | 2019 | 1409 | 0.450 |
Why?
|
Hypersensitivity, Immediate | 1 | 2016 | 348 | 0.430 |
Why?
|
Thrombocytopenia | 1 | 2021 | 1179 | 0.420 |
Why?
|
Electronic Health Records | 6 | 2022 | 4884 | 0.380 |
Why?
|
Blood Platelets | 1 | 2021 | 2479 | 0.350 |
Why?
|
Health Personnel | 3 | 2021 | 3385 | 0.350 |
Why?
|
Occupational Exposure | 1 | 2020 | 1807 | 0.330 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3115 | 0.300 |
Why?
|
Vaccines, Synthetic | 2 | 2021 | 621 | 0.300 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3238 | 0.300 |
Why?
|
Communication | 3 | 2023 | 3904 | 0.290 |
Why?
|
Anti-Bacterial Agents | 6 | 2019 | 7470 | 0.240 |
Why?
|
Medicine, African Traditional | 1 | 2004 | 31 | 0.230 |
Why?
|
Documentation | 4 | 2022 | 917 | 0.210 |
Why?
|
Midwifery | 1 | 2004 | 131 | 0.200 |
Why?
|
Asthma, Aspirin-Induced | 2 | 2016 | 204 | 0.190 |
Why?
|
Penicillins | 3 | 2023 | 404 | 0.190 |
Why?
|
Food Hypersensitivity | 2 | 2022 | 734 | 0.180 |
Why?
|
Medical Order Entry Systems | 2 | 2015 | 523 | 0.170 |
Why?
|
Decision Support Systems, Clinical | 3 | 2019 | 1178 | 0.170 |
Why?
|
Organoplatinum Compounds | 1 | 2021 | 406 | 0.170 |
Why?
|
Toilet Facilities | 1 | 2019 | 26 | 0.160 |
Why?
|
Academic Medical Centers | 2 | 2020 | 2783 | 0.160 |
Why?
|
Current Procedural Terminology | 1 | 2019 | 101 | 0.160 |
Why?
|
Vaccination | 5 | 2021 | 3437 | 0.160 |
Why?
|
Personnel, Hospital | 1 | 2021 | 285 | 0.160 |
Why?
|
Delayed Diagnosis | 2 | 2020 | 467 | 0.160 |
Why?
|
Humans | 56 | 2024 | 767991 | 0.160 |
Why?
|
Platelet Count | 1 | 2021 | 787 | 0.150 |
Why?
|
Urticaria | 1 | 2019 | 151 | 0.150 |
Why?
|
Drug Eruptions | 1 | 2021 | 335 | 0.150 |
Why?
|
Boston | 3 | 2021 | 9368 | 0.150 |
Why?
|
Angioedema | 1 | 2019 | 184 | 0.150 |
Why?
|
Nausea | 1 | 2021 | 682 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 249 | 0.140 |
Why?
|
Delivery, Obstetric | 1 | 2004 | 954 | 0.140 |
Why?
|
Angioedemas, Hereditary | 1 | 2018 | 91 | 0.140 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2271 | 0.130 |
Why?
|
Radiology | 2 | 2022 | 2104 | 0.130 |
Why?
|
Hospitals, General | 1 | 2021 | 806 | 0.130 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 388 | 0.130 |
Why?
|
Adverse Drug Reaction Reporting Systems | 2 | 2022 | 496 | 0.130 |
Why?
|
Stevens-Johnson Syndrome | 2 | 2016 | 231 | 0.130 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 709 | 0.130 |
Why?
|
Insurance Claim Review | 1 | 2019 | 743 | 0.120 |
Why?
|
Hypotension | 1 | 2021 | 888 | 0.120 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2016 | 361 | 0.120 |
Why?
|
Disclosure | 1 | 2020 | 755 | 0.110 |
Why?
|
Clinical Alarms | 1 | 2015 | 61 | 0.110 |
Why?
|
Inpatients | 4 | 2019 | 2570 | 0.110 |
Why?
|
Diffusion of Innovation | 1 | 2019 | 724 | 0.110 |
Why?
|
International Classification of Diseases | 1 | 2019 | 936 | 0.110 |
Why?
|
Physicians | 2 | 2022 | 4598 | 0.110 |
Why?
|
Databases as Topic | 1 | 2015 | 472 | 0.110 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2021 | 951 | 0.110 |
Why?
|
Patients | 1 | 2020 | 908 | 0.110 |
Why?
|
Cost Savings | 1 | 2019 | 904 | 0.110 |
Why?
|
Practice Guidelines as Topic | 4 | 2019 | 7445 | 0.110 |
Why?
|
Patient Satisfaction | 3 | 2022 | 3488 | 0.110 |
Why?
|
Hypersensitivity, Delayed | 1 | 2014 | 491 | 0.110 |
Why?
|
Vancomycin | 1 | 2016 | 504 | 0.100 |
Why?
|
Burnout, Professional | 1 | 2021 | 711 | 0.100 |
Why?
|
Pandemics | 6 | 2023 | 8748 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1086 | 0.100 |
Why?
|
Occupational Diseases | 1 | 2020 | 1457 | 0.100 |
Why?
|
Cross Infection | 1 | 2020 | 1426 | 0.090 |
Why?
|
Nasal Polyps | 1 | 2016 | 412 | 0.090 |
Why?
|
Drug Utilization | 1 | 2017 | 1190 | 0.090 |
Why?
|
Respiration Disorders | 1 | 2014 | 364 | 0.090 |
Why?
|
Respiratory Sounds | 2 | 2014 | 702 | 0.090 |
Why?
|
Delivery of Health Care | 4 | 2022 | 5366 | 0.080 |
Why?
|
Incidence | 4 | 2021 | 21532 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2533 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2021 | 2540 | 0.080 |
Why?
|
Family | 1 | 2020 | 3210 | 0.080 |
Why?
|
Hemorrhage | 1 | 2021 | 3467 | 0.080 |
Why?
|
Thalidomide | 1 | 2014 | 886 | 0.080 |
Why?
|
Consensus | 1 | 2018 | 3210 | 0.080 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2011 | 184 | 0.080 |
Why?
|
Asthma | 2 | 2021 | 6273 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2015 | 1542 | 0.070 |
Why?
|
Algorithms | 2 | 2020 | 14163 | 0.070 |
Why?
|
Ethanol | 1 | 2014 | 1331 | 0.070 |
Why?
|
Adult | 11 | 2021 | 223583 | 0.070 |
Why?
|
Female | 18 | 2022 | 397113 | 0.070 |
Why?
|
Allergens | 3 | 2022 | 1434 | 0.070 |
Why?
|
Cephalosporins | 2 | 2019 | 200 | 0.070 |
Why?
|
RNA, Messenger | 4 | 2021 | 12797 | 0.070 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13658 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5717 | 0.060 |
Why?
|
Gender Identity | 2 | 2021 | 770 | 0.060 |
Why?
|
Middle Aged | 12 | 2021 | 223422 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2024 | 81746 | 0.060 |
Why?
|
Male | 16 | 2021 | 364641 | 0.060 |
Why?
|
Camphor | 1 | 2004 | 9 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2014 | 1594 | 0.060 |
Why?
|
Nicaragua | 1 | 2004 | 29 | 0.060 |
Why?
|
Prospective Studies | 4 | 2021 | 54924 | 0.060 |
Why?
|
Cohort Studies | 4 | 2021 | 41749 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3109 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 8082 | 0.060 |
Why?
|
Umbilical Cord | 1 | 2004 | 179 | 0.050 |
Why?
|
Amoxicillin | 1 | 2023 | 181 | 0.050 |
Why?
|
Anemia | 1 | 2011 | 1514 | 0.050 |
Why?
|
Excipients | 1 | 2021 | 96 | 0.050 |
Why?
|
Massachusetts | 3 | 2020 | 8888 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12252 | 0.040 |
Why?
|
Opioid-Related Disorders | 1 | 2015 | 2188 | 0.040 |
Why?
|
Ambulatory Care | 2 | 2022 | 2781 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9252 | 0.040 |
Why?
|
User-Computer Interface | 2 | 2015 | 1407 | 0.040 |
Why?
|
Danazol | 1 | 2018 | 44 | 0.040 |
Why?
|
United States | 7 | 2020 | 73027 | 0.040 |
Why?
|
Faculty | 1 | 2021 | 383 | 0.040 |
Why?
|
Spirometry | 1 | 2021 | 929 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2021 | 26375 | 0.030 |
Why?
|
Expert Testimony | 1 | 2018 | 266 | 0.030 |
Why?
|
Hospitals, Urban | 1 | 2019 | 496 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2020 | 878 | 0.030 |
Why?
|
Problem Solving | 1 | 2019 | 443 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5196 | 0.030 |
Why?
|
Republic of Korea | 1 | 2018 | 591 | 0.030 |
Why?
|
Systematized Nomenclature of Medicine | 1 | 2015 | 35 | 0.030 |
Why?
|
Young Adult | 3 | 2019 | 60048 | 0.030 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2016 | 82 | 0.030 |
Why?
|
Critical Pathways | 1 | 2019 | 476 | 0.030 |
Why?
|
Radiology Department, Hospital | 1 | 2019 | 409 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2018 | 599 | 0.030 |
Why?
|
Nephritis, Interstitial | 1 | 2016 | 157 | 0.030 |
Why?
|
Policy | 1 | 2018 | 513 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.030 |
Why?
|
Vocabulary, Controlled | 1 | 2015 | 170 | 0.030 |
Why?
|
Hospitalization | 3 | 2020 | 10840 | 0.030 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2015 | 198 | 0.030 |
Why?
|
Leukotriene E4 | 1 | 2014 | 75 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2018 | 812 | 0.030 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2014 | 87 | 0.030 |
Why?
|
Quality Improvement | 2 | 2019 | 3855 | 0.030 |
Why?
|
Utilization Review | 1 | 2015 | 381 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 937 | 0.030 |
Why?
|
Aged | 7 | 2020 | 171446 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 985 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3628 | 0.030 |
Why?
|
Standard of Care | 1 | 2017 | 568 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1671 | 0.020 |
Why?
|
International Cooperation | 1 | 2018 | 1434 | 0.020 |
Why?
|
Exanthema | 1 | 2017 | 502 | 0.020 |
Why?
|
Emotions | 1 | 2023 | 2766 | 0.020 |
Why?
|
Drug Interactions | 1 | 2015 | 1419 | 0.020 |
Why?
|
Self Report | 1 | 2021 | 3773 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2016 | 1497 | 0.020 |
Why?
|
Outpatients | 1 | 2017 | 1600 | 0.020 |
Why?
|
Medication Errors | 1 | 2015 | 784 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1207 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5314 | 0.020 |
Why?
|
Adolescent | 1 | 2016 | 89155 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10627 | 0.020 |
Why?
|
Pregnancy | 2 | 2011 | 30260 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2017 | 2008 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2015 | 1203 | 0.020 |
Why?
|
Dyspnea | 1 | 2014 | 1352 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3886 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8740 | 0.020 |
Why?
|
Computational Biology | 1 | 2016 | 3568 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22287 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20218 | 0.010 |
Why?
|
Risk Factors | 2 | 2021 | 74936 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2017 | 59598 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15867 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40214 | 0.010 |
Why?
|
Infant | 1 | 2011 | 36534 | 0.000 |
Why?
|
Child, Preschool | 1 | 2011 | 42665 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2014 | 65364 | 0.000 |
Why?
|
Child | 1 | 2011 | 80906 | 0.000 |
Why?
|